三尖瓣反流外科矫治中修复术与置换术的比较:一项荟萃分析
该荟萃分析纳入17项回顾性研究共4561例患者(三尖瓣修复组3432例,三尖瓣置换组1129例),比较两种术式治疗三尖瓣反流的效果。汇总分析显示三尖瓣置换组全因死亡风险显著高于修复组(HR 1.59,95%CI 1.26-2.00),两组三尖瓣再手术和瓣膜相关事件无显著差异。作者认为修复术在全因死亡方面更有利。
要点
- 三尖瓣置换组全因死亡风险显著高于修复组(HR 1.59,95%CI 1.26-2.00)。
- 两组三尖瓣再手术风险无显著差异(HR 1.30,95%CI 0.88-1.91,6项研究)。
- 两组瓣膜相关事件无显著差异(HR 1.47,95%CI 0.91-2.38,5项研究)。
核心结论
- 该荟萃分析表明,就全因死亡而言,三尖瓣修复术较三尖瓣置换术更有利。
- 根据现有数据,与三尖瓣置换术相比,三尖瓣修复术不增加三尖瓣再手术风险。
研究设计与样本
- 研究检索了5个数据库,纳入17项回顾性研究,共4561例患者,其中三尖瓣修复组3432例,三尖瓣置换组1129例。
- 主要结局为全因死亡,次要结局为三尖瓣再手术和瓣膜相关事件。
- 亚组分析按偏倚风险、发表年份、三尖瓣反流≥3级患者比例、功能性病因比例及孤立三尖瓣手术比例进行。
- 采用漏斗图和Egger检验探索发表偏倚。
主要发现
- 汇总分析显示,三尖瓣置换组全因死亡风险显著高于三尖瓣修复组,风险比(95%置信区间)为1.59(1.26-2.00)。
- 6项研究中两组三尖瓣再手术风险无显著差异,风险比(95%置信区间)为1.30(0.88-1.91)。
- 5项研究中两组瓣膜相关事件无显著差异,风险比(95%置信区间)为1.47(0.91-2.38)。
- 所有亚组分析均未显示全因死亡风险比有显著差异。
- 主要和次要结局均未发现发表偏倚。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tricuspid valve repair (TVr) has both a theoretical advantage in preserving right ventricular function and disadvantages such as a higher risk of repair failure in the long-term compared with tricuspid valve replacement (TVR). This study was conducted to compare the results of TVr with those of TVR to find an optimal treatment option. METHODS: A literature search of 5 databases was performed. The primary outcome was all-cause mortality. Secondary outcomes were tricuspid reoperation and valve-related events. Subgroup analyses were performed according to the risk of bias, year of publication and proportions of patients with tricuspid regurgitation Grade ≥3, functional aetiology and isolated tricuspid valve surgery. Publication bias was explored using the funnel plot and Egger's test. RESULTS: Seventeen retrospective studies involving 4561 patients (TVr group = 3432 patients and TVR group = 1129 patients) were included. A pooled analysis showed that the risk of all-cause mortality was significantly higher in the TVR group than in the TVr group [hazard ratio (95% confidence interval) 1.59 (1.26-2.00)]. There were no significant differences in tricuspid valve reoperation in 6 studies and valve-related events in 5 studies between the TVR and TVr groups [hazard ratio (95% confidence interval) 1.30 (0.88-1.91) and 1.47 (0.91-2.38), respectively]. None of the subgroup analyses demonstrated a significant difference in the hazard ratio of all-cause mortality. No publication bias was identified for the primary and secondary outcomes. CONCLUSIONS: This meta-analysis indicates that TVr is more beneficial compared with TVR in terms of all-cause mortality. From the available data, TVr is not associated with an increased risk of tricuspid reoperation compared with TVR.
引用
- Choi JW, Jang MJ, Kim KH, et al. Repair versus replacement for the surgical correction of tricuspid regurgitation: a meta-analysis. Eur J Cardiothorac Surg. 2018. PMID: 29228165. doi:10.1093/ejcts/ezx420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。